ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy

Clinical trial NCT03145298 · COMPLETED

Trial details

NCT number: NCT03145298
Sponsor: Cedars-Sinai Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension (PAH)

Start date: 2017-10-01
Primary completion: 2023-01-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.